Teva Pharma (TEVA) call put ratio 1.7 calls to 1 put as share price down 0.79%
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
Tweet
Share
E-mail
Get Alerts TEVA Hot Sheet
Price: $40.62 -0.56%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 2.1%
Revenue Growth %: -5.1%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 2.1%
Revenue Growth %: -5.1%
Join SI Premium – FREE
Teva Pharma (NYSE: TEVA) 30-day option implied volatility is at 32; compared to its 52-week range of 29 to 66. Call put ratio 1.7 calls to 1 put as share price down 0.79%.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Raytheon wins $394M contract extension for Army radar systems
- Qiagen posts $548M in Q3 2026 net sales amid pending EQT deal
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
Create E-mail Alert Related Categories
OptionsRelated Entities
Options, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
